Interpol announced the results of Operation Pangea and U.S. CBP reported on pill press seizures. News about counterfeit medicine in the U.S, Belgium, China, and Indonesia,
Read More
FDA warned about contamination in 26 different over-the-counter eye drops. Ten New York residents were indicted in another black market HIV medicine scheme. Additional stories in California, Florida, and Texas.
Read More
Risk Statement: Consumption of undeclared diclofenac could result in serious adverse events that include cardiovascular, gastrointestinal, renal, and anaphylaxis in patients taking concomitant NSAIDs and/or anticoagulants, such as Warfarin, in those who have allergies to diclofenac, or those with underlying cardiovascular, gastrointestinal, renal, and hepatic illnesses.
Read More
A delay in Florida’s response to FDA questions means the agency’s decision won’t be by October 31 after all.
Read More
Sketchy online vendors are selling “retatrutide” even though it’s still in clinical trials. A man who sold U.S. pharmacies secondhand prescription medicines was sentenced. Domestic and international stories about fake drugs.
Read More
Almost 200 packages of fake Ozempic traveled from Austria to the U.K. via Germany. An 11th man was sentenced in a $52mm cough medicine counterfeiting scheme. Europol reports the seizure of medical products. Additional news about pill presses in Mexico and the U.S.
Read More
The leaders of the “Genesis II Church of Health and Healing” received a cumulative 34 years in prison. A NYC pharmacist pleaded guilty to fraud and money laundering after selling black market HIV drugs. Pill press operations busted in NYC and Rhode Island.
Read More
The FDA is cracking down on lax safety testing of raw drug ingredients. Major players in HIV drug and cough syrup counterfeiting schemes pleaded guilty in federal court.
Counterfeit Avastin in Pakistan blinded over 70 retinopathy patients.
CBP at JFK Airport intercepted 14 pairs of pill press dies. Additional news about illicit pill presses in five states.
Read More
Shabbir Imber Safdar, executive director of the Partnership for Safe Medicines, will participate in the upcoming United States Patent and Trademark Office Roundtable: Future strategies in anti-counterfeiting and anti-piracy.
Read More
USFDA is concerned that eight companies, including two pharmacies, are illegally marketing unapproved ophthalmic drug products that pose a heightened risk to users. Counterfeit pills make the DHS’ threat assessment list for 2024.
Read More